Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Malignant urinary tract neoplasm: Which Medications Are Safest? (49 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

49 medications are used for Malignant urinary tract neoplasm, with 530 combined adverse event reports. The most reported drugs for Malignant urinary tract neoplasm are BEVACIZUMAB and PAZOPANIB.

530
Total Reports
49
Drugs Used

All Medications for Malignant urinary tract neoplasm Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
BEVACIZUMAB JOBEVNE 156 17,498 23,114 22.4%
PAZOPANIB Pazopanib 97 5,612 4,347 26.5%
ERLOTINIB Erlotinib 75 6,791 3,693 30.2%
ATEZOLIZUMAB Tecentriq Hybreza 73 8,520 15,094 25.3%
CABOZANTINIB S-MALATE CABOMETYX 31 4,203 6,193 10.7%
SUNITINIB MALATE Sunitinib malate 28 6,028 5,720 27.9%
AXITINIB INLYTA 23 3,141 4,050 19.8%
EVEROLIMUS EVEROLIMUS 13 8,374 11,211 21.1%
PEMBROLIZUMAB KEYTRUDA 11 15,543 35,472 18.6%
SUTENT - 9 386 259 32.2%
CAPECITABINE Capecitabine 8 8,892 17,529 14.0%
NIVOLUMAB OPDIVO 8 23,086 36,530 26.3%
INLYTA - 7 113 75 22.3%
VOTRIENT - 7 244 207 40.3%

View all 49 drugs →

Most Reported Drugs for Malignant urinary tract neoplasm

#1 most reported
#2 most reported
#3 most reported